106 related articles for article (PubMed ID: 18349276)
1. Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup.
Schildkraut JM; Moorman PG; Bland AE; Halabi S; Calingaert B; Whitaker R; Lee PS; Elkins-Williams T; Bentley RC; Marks JR; Berchuck A
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):585-93. PubMed ID: 18349276
[TBL] [Abstract][Full Text] [Related]
2. Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies.
Pelucchi C; Galeone C; Talamini R; Bosetti C; Montella M; Negri E; Franceschi S; La Vecchia C
Am J Obstet Gynecol; 2007 Jan; 196(1):83.e1-7. PubMed ID: 17240246
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptive use and cyclin D1 overexpression in breast cancer among young women.
Terry MB; Gammon MD; Schoenberg JB; Brinton LA; Arber N; Hibshoosh H
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1100-3. PubMed ID: 12376514
[TBL] [Abstract][Full Text] [Related]
4. Cyclin E mRNA overexpression in epithelial ovarian cancers: inverse correlation with p53 protein accumulation.
Sawasaki T; Shigemasa K; Shiroyama Y; Kusuda T; Fujii T; Parmley TH; O'Brien TJ; Ohama K
J Soc Gynecol Investig; 2001; 8(3):179-85. PubMed ID: 11390254
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant medication use [corrected] and risk of ovarian cancer.
Moorman PG; Berchuck A; Calingaert B; Halabi S; Schildkraut JM
Obstet Gynecol; 2005 Apr; 105(4):725-30. PubMed ID: 15802397
[TBL] [Abstract][Full Text] [Related]
6. Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.
Terry KL; Titus-Ernstoff L; McKolanis JR; Welch WR; Finn OJ; Cramer DW
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):30-5. PubMed ID: 17220329
[TBL] [Abstract][Full Text] [Related]
7. Influence of reproductive factors on mortality after epithelial ovarian cancer diagnosis.
Robbins CL; Whiteman MK; Hillis SD; Curtis KM; McDonald JA; Wingo PA; Kulkarni A; Marchbanks PA
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2035-41. PubMed ID: 19589914
[TBL] [Abstract][Full Text] [Related]
8. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Epidemiology; 2008 Mar; 19(2):237-43. PubMed ID: 18223481
[TBL] [Abstract][Full Text] [Related]
9. Relations of gestational length and timing and type of incomplete pregnancy to ovarian cancer risk.
Gierach GL; Modugno F; Ness RB
Am J Epidemiol; 2005 Mar; 161(5):452-61. PubMed ID: 15718481
[TBL] [Abstract][Full Text] [Related]
10. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study.
Soegaard M; Jensen A; Høgdall E; Christensen L; Høgdall C; Blaakaer J; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1160-6. PubMed ID: 17548679
[TBL] [Abstract][Full Text] [Related]
11. Gender of offspring and maternal risk of invasive epithelial ovarian cancer.
Baik I; Lambe M; Liu Q; Cnattingius S; Mucci LA; Riman T; Ekbom A; Adami HO; Hsieh CC
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2314-20. PubMed ID: 18006920
[TBL] [Abstract][Full Text] [Related]
12. Plasma carotenoids, retinol and tocopherol levels and the risk of ovarian cancer.
Jeong NH; Song ES; Lee JM; Lee KB; Kim MK; Cheon JE; Lee JK; Son SK; Lee JP; Kim JH; Hur SY; Kwon YI
Acta Obstet Gynecol Scand; 2009; 88(4):457-62. PubMed ID: 19266359
[TBL] [Abstract][Full Text] [Related]
13. Gender of offspring and maternal ovarian cancer risk.
Gierach GL; Modugno F; Ness RB
Gynecol Oncol; 2006 Jun; 101(3):476-80. PubMed ID: 16364411
[TBL] [Abstract][Full Text] [Related]
14. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Allen GO; Ness RB
Obstet Gynecol; 2005 Apr; 105(4):731-40. PubMed ID: 15802398
[TBL] [Abstract][Full Text] [Related]
15. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of cyclin E in low-risk node negative breast cancer.
Ahlin C; Gruhne B; Holmqvist M; Zetterberg A; Fjällskog ML
Acta Oncol; 2008; 47(8):1539-45. PubMed ID: 18607847
[TBL] [Abstract][Full Text] [Related]
17. Beyond parity: association of ovarian cancer with length of gestation and offspring characteristics.
Jordan SJ; Green AC; Nagle CM; Olsen CM; Whiteman DC; Webb PM; ;
Am J Epidemiol; 2009 Sep; 170(5):607-14. PubMed ID: 19638480
[TBL] [Abstract][Full Text] [Related]
18. Short-term oral contraceptive use and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Allen GO; Ness RB
Am J Epidemiol; 2005 Jul; 162(1):66-72. PubMed ID: 15961588
[TBL] [Abstract][Full Text] [Related]
19. Analgesic drug use and risk of epithelial ovarian cancer.
Hannibal CG; Rossing MA; Wicklund KG; Cushing-Haugen KL
Am J Epidemiol; 2008 Jun; 167(12):1430-7. PubMed ID: 18390840
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
